Characterization of binding interactions of SARS-CoV-2 spike protein and DNA-peptide nanostructures
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization of binding interactions of SARS-CoV-2 spike protein and DNA-peptide nanostructures ; volume:12 ; number:1 ; day:27 ; month:7 ; year:2022 ; pages:1-12 ; date:12.2022
Scientific reports ; 12, Heft 1 (27.7.2022), 1-12, 12.2022
- Urheber
-
Kruse, Marlen
Altattan, Basma
Laux, Eva-Maria
Grasse, Nico
Heinig, Lars
Möser, Christin
Smith, David M.
Hölzel, Ralph
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-16914-9
- URN
-
urn:nbn:de:101:1-2022100821463770983137
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kruse, Marlen
- Altattan, Basma
- Laux, Eva-Maria
- Grasse, Nico
- Heinig, Lars
- Möser, Christin
- Smith, David M.
- Hölzel, Ralph
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stabilizing the closed SARS-CoV-2 spike trimer
Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
Computational epitope map of SARS-CoV-2 spike protein
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
Characterization of a SARS-CoV-2 spike protein reference material
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
SARS‐CoV‐2 Spike Protein‐Derived Cyclic Peptides as Modulators of Spike Interaction with GRP78
Stabilizing the closed SARS-CoV-2 spike trimer
Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
Computational epitope map of SARS-CoV-2 spike protein
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
Characterization of a SARS-CoV-2 spike protein reference material
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
SARS‐CoV‐2 Spike Protein‐Derived Cyclic Peptides as Modulators of Spike Interaction with GRP78
Stabilizing the closed SARS-CoV-2 spike trimer
Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
Computational epitope map of SARS-CoV-2 spike protein
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
Characterization of a SARS-CoV-2 spike protein reference material
Potential antiviral peptides targeting the SARS-CoV-2 spike protein